The desk.
Three contributors split the desk by topic specialty. Each writes under a pen name for operational reasons — the grey-market context makes real-name bylines impractical for the writers and risky for our lab partners. The tradeoff is real and we'd rather work pseudonymously than not at all.
Mara Hollis
Mara leads the vendor-audit desk at vialaudit. Before this she spent a decade covering pharmaceutical-supply transparency for trade publications, and a stint as an analyst at a generics-compounding firm — which is where she learned how COA practices vary in the wild and why most vendor reviews online aren't worth the bytes they're written in. Mara handles the vendor relationships, the audit-cycle calendar, the methodology page, and the corrections feed. She does not accept retainers, sponsored content, or paid feature placements. Vendors do not get to review their audits before publication. That's the job. She writes under a pen name. The grey-market context makes real-name bylines impractical for the writers and risky for the labs. The tradeoff is real and we'd rather work pseudonymously than not at all.
Sara Vance
Sara writes the peptide guides, the mechanism explainers, and the research-literature reviews. Her background is in pharmacology research — eight years at a contract research organization running preclinical pharmacokinetics work before moving into science writing full-time. She reads the primary research literature so vialaudit readers don't have to, and she's the person on the desk who decides which peptide is mature enough for a guide. If a compound only has rodent data, she says so. If a Phase 2 trial is being misrepresented in community discussion, she writes the literature read. Sara writes under a pen name. The peptide research-protocol space attracts strong opinions and direct outreach to authors; she'd rather keep the email volume manageable and the work honest.
Eli Whitmer
Eli runs the lab-data side of the desk: COA reading, chromatogram interpretation, the Janoshik corpus, and the COA verifier tool. His background is analytical chemistry — twelve years in HPLC-MS method development at QC labs serving the supplements and pharmaceutical industries. He's the reason vialaudit asks specific questions about peak shape, integration windows, and signal-to-noise rather than just citing the purity percentage at the bottom of a report. If a vendor's COA uses a method that wouldn't pass an FDA inspection, Eli writes about it. Eli writes under a pen name. He still works in the analytical-chem world; a public byline on grey-market peptide commentary would be career-difficult. The pseudonymity is the price of getting the analysis at all.
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.